EMILY WEISSGARBER: Open Payments
NPI 1134784705 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$774 in 6 payments from 6 companies in 2025. Trend: 2023 $245 · 2024 $353 · 2025 $774
Food & beverage: $774
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $168 |
| Teva Pharmaceuticals USA, Inc. | 1 | $135 |
| Alkermes, Inc. | 1 | $130 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $125 |
| SI-BONE, INC. | 1 | $92 |
Products named: TEPEZZA, LYBALVI, Auvelity, VRAYLAR.
Industry payments across TX — which companies pay providers there.
